<SEC-DOCUMENT>0001144204-13-040981.txt : 20130724
<SEC-HEADER>0001144204-13-040981.hdr.sgml : 20130724
<ACCEPTANCE-DATETIME>20130724172731
ACCESSION NUMBER:		0001144204-13-040981
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130722
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130724
DATE AS OF CHANGE:		20130724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		13984340

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v350811_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND
EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Section&nbsp;13 OR 15(d)
of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>The Securities Exchange
Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported)<B>
July 22, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Medifast, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant
as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt; color: black"><B>DE</B></FONT></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>001-31573</B></P></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>13-3714405</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(State or
other jurisdiction of incorporation)</P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt; color: black">(Commission File Number)</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt; color: black">(IRS Employer Identification No.)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66%; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>11445 Cronhill Drive, Owings Mills, Maryland</B></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>21117</B></P></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: black">(Address of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: black">(Zip Code)</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&rsquo;s telephone number, including
area code: &nbsp;<B> 410-581-8042</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0 0 0 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%; text-align: center">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former
address, if changed since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I> see</I> General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 5.02</B></TD><TD><B>Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 5.02(d)</B></TD><TD><B>Appointment of Mr. Sassano and Mr. Bondroff</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective July 22, 2013, the Board of Directors
of Medifast, Inc. (the &ldquo;Company&rdquo;) appointed Carl E. Sassano to its Board of Directors and the Company's Compensation
Committee. The Board also appointed Director Barry B. Bondroff, CPA, as Lead Director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: #2D2D2D">Mr. Sassano&nbsp;has more than
40 years of significant corporate experience. &nbsp;Mr. Sassano is a Partner in&nbsp;CSW Equity Partners, a private equity investment
company and serves as Chairman of the&nbsp;Board of Voiceport, a company in the CSW portfolio. &nbsp;Mr. Sassano is currently a
member of the Board of Transcat, Inc., serves as their Lead Director, and was Chairman of the Board from&nbsp;October 2003&nbsp;until
July, 2013.&nbsp; From 1999 to 2000,&nbsp;Mr. Sassano&nbsp;was President and Chief Operating Officer of&nbsp;Bausch &amp; Lomb&nbsp;and
held a number of other senior executive positions there including President-Global Vision Care from 1996 to 1999, President-Contact
Lens Division from 1994 to 1996, Group President from 1993 to 1994 and President-Polymer Technology, a subsidiary of&nbsp;Bausch
&amp; Lomb, from 1983 to 1992.&nbsp;</FONT> There has been no reportable transaction since the beginning of the last fiscal year
and none is currently proposed in which the Company was or is to be a participant in which Mr. Sassano had or has any direct or
indirect material interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #2D2D2D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #2D2D2D">Mr. Bondroff&nbsp;has served as a Director on
the Medifast Board since 2008.&nbsp; He is an officer and director with Gorfine, Schiller &amp; Gardyn, PA, a full-service certified
public accounting firm offering a wide range of accounting and consulting services. Previously, he was a Senior Managing Director
with SMART, which merged with Gorfine, Schiller &amp; Gardyn in&nbsp;May 2003.&nbsp;Mr. Bondroff&nbsp;has over 42 years of experience
providing companies of all sizes and across varied industries with practical accounting, assurance, tax, business, technology and
financial advisory services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of the press release announcing the appointments is attached
to this Current Report as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><U>Exhibit No.</U></TD><TD><U>Description</U></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left">99.1</TD><TD>Press release
issued by the Company on July 23, 2013</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the
requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><B>Medifast, Inc.</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: July 24, 2013</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ TIMOTHY G. ROBINSON</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Timothy G. Robinson<BR>Chief Financial Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v350811_ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 99.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><img src="logo.jpg"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Medifast, Inc. Announces Appointments
of New Independent Director &amp; Lead Director</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">OWINGS
MILLS, Md.,&nbsp;July 23, 2013&nbsp;/PRNewswire/ --&nbsp;Medifast, Inc.&nbsp;(NYSE: MED), a leading&nbsp;United States&nbsp;manufacturer
and provider of clinically proven, portion-controlled weight-loss products and programs, today announced the appointment of&nbsp;Carl
E. Sassano&nbsp;to the Medifast Board of Directors and&nbsp;Barry B. Bondroff, CPA, as Lead Director, effective&nbsp;July 22, 2013.&nbsp;&nbsp;Mr.
Sassano&nbsp;will also serve on the Company&rsquo;s Compensation Committee.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">Mr.
Sassano&nbsp;joins the board with over 40 years of significant corporate experience. &nbsp;Mr. Sassano is a Partner in&nbsp;CSW
Equity Partners, a private equity investment company and serves as Chairman of the&nbsp;Board of Voiceport, a company in the CSW
portfolio. &nbsp;Mr. Sassano is currently a member of the Board of Transcat, Inc., serves as their Lead Director, and was Chairman
of the Board from&nbsp;October 2003&nbsp;until July, 2013.&nbsp; From 1999 to 2000,&nbsp;Mr. Sassano&nbsp;was President and Chief
Operating Officer of&nbsp;Bausch &amp; Lomb&nbsp;and held a number of other senior executive positions there including President-Global
Vision Care from 1996 to 1999, President-Contact Lens Division from 1994 to 1996, Group President from 1993 to 1994 and President-Polymer
Technology, a subsidiary of&nbsp;Bausch &amp; Lomb, from 1983 to 1992.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">&ldquo;We
are excited to announce the appointment of Carl to our Board. &nbsp;Carl is a tremendous&nbsp;leader and his extensive experience
at Transcat and&nbsp;Bausch &amp; Lomb&nbsp;will enable him to make meaningful contributions to the Board,&rdquo; commented&nbsp;Michael
C. MacDonald,&nbsp;Medifast&rsquo;s&nbsp;Chairman and CEO. &ldquo;Carl has a strong understanding of consumer facing organizations and
as&nbsp;Medifast continues to implement our growth strategy, Carl&rsquo;s background and contributions will be invaluable.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">Mr.
Bondroff&nbsp;has served as a Director on the Medifast Board since 2008.&nbsp; He is an officer and director with Gorfine, Schiller
&amp; Gardyn, PA, a full-service certified public accounting firm offering a wide range of accounting and consulting services.
Previously, he was a Senior Managing Director with SMART, which merged with Gorfine, Schiller &amp; Gardyn in&nbsp;May 2003.&nbsp;Mr.
Bondroff&nbsp;has over 42 years of experience providing companies of all sizes and across varied industries with practical accounting,
assurance, tax, business, technology and financial advisory services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #2D2D2D">Mr.
MacDonald&nbsp;concluded, &ldquo;Barry&rsquo;s leadership and insights have been instrumental to the growth of&nbsp;Medifast&nbsp;over
the years, and in his new role as Lead Director, he will continue to provide guidance and oversight as we execute our strategic
initiatives, expand our reach and profitability, and continue to develop our multi-channel distribution network across Take Shape
for Life, Medifast Direct, Medifast Weight Control Centers, and Wholesale Physicians.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About&nbsp;Medifast&nbsp;</B><BR>
Medifast&nbsp;(NYSE: MED) is the leading easy-to-use, clinically proven, portion-controlled weight-loss
program. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers,
2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians.&nbsp;Medifast&nbsp;was
founded in 1980 and is located in&nbsp;Owings Mills, Maryland. For more information, log onto www.MedifastNow.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MED-G</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Contact: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Timothy Robinson&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ir@choosemedifast.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ICR, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Katie Turner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(646) 277-1228</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!D`/4#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B
MLW5?&>CZ%?PVM]JVFV=U<$"*&>Z2.20GLJD@G\*^</VO/^"OGP;_`&)/CCHG
MP_\`&]]KJZWJT,5S/+8V`GM=)AD<JDEPY=2`=K'$:NP`R0,C/7A<#B,3/V>'
M@Y.S=DKZ+<Y<5CL/AH>TKS45>UV^K/J&BHH[^&7R@LT9,Z[HQN&7&,Y'KQ4M
M<K.JX4444@"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`/FG]L__@FGX-_:>;5O$MAI&B6GQ&O(XPFIZE)J#VEQY:!$
MCFAMKJ#@J%7>#N`4<-C%?E[^TQ\"M7_9)\;/H7C?2/@_IMR4\R"Y;0O&]W8W
M:8^]'-'/)&^#P1U'<<C/[L5G^+/"UGXV\-7ND:@L[V6H1&&80W$EO+M/=9(V
M5T8=0RD$'D&OILHXFQ&$M3JMSAVO9KT;3T\K?<?.9MPY0Q=ZE-*,^]KI^J36
MOG^9_-G\;?C+IOPSM(Y[2W^#&JZC<!'CTNU^&ER!-$3S+)<:I$LP0@$`QLQ)
MQC')KA?BG^T_I7QU\;?#[6]>L(`?#.VSN[:\%Q?JME&ZO%;!VEWSVZ?O!''(
MXD56\MI714*?I?\`MU_`OQE^P5\8M)?PEK'Q1\+_``;U'2WN-8\8^'-(A\3:
M[-J_GRN7U6:<K-)`L1C1-SA`J``%MQ/S!X\^)'P'^('B_P"$M]XK^*'@SX@Z
MHOB#5Y?$?B-_A_/H\D%BUD@L1J%K%&HO"ERA8[2Q(<H69?FK]8R[,J-6G&O3
MIN2:=G&[EL]':'*GI:SES7:/RW,,OK4JDJ-2HHM-73LENM5>?,UK>ZC:R9Y?
M8?ML6_Q^^+%[<Z[I_P`/;;4+TETUSQS:ZGJMYJ4I./WMU:-YEJ<'Y$M(8HD`
MV@+@$^F^&/&%CJ.OVFE:9K?P4N-6NY!;V]GI7C#XAS7$LA.-B11,S%B>-HK8
M\`:#X@_:"O?#?@GX0>+]7^-\KZK##JUJ/A?9Z-X%L+0OF7SW95D'RG(81QOC
M)0AMF?VA_9A_90T/]EGPI-I>EZQXJ\1/+,SK>>(=5DU&XMX\G9!&S\)&BG:`
M!D@98L>:\7/L\PV`C&,8M2>T5)JR75IQ37DFM>FA[&1Y-B,=)R<DTMY.*=V^
MB:DT_-IZ=3Y0_95_X)(WVL^;J'QDBL([5D22PT_PWXU\5M(Q(!+3M=7HVX&5
M\L(3R<L.A^^-+TR#1=,MK*VC\JVM(EAB0$D(B@!1D\\`#K7S;_P5ZM+VQ_8#
M^('B/2?%7B?P=KOA"P.K:=J.B:I-83"9&`$3F-@'CDSL*MG[P(P0#7X7_LP?
M\%4_C1\.?VB_!&M^(OBU\0-6\.Z=K=I+JUG?ZY<W5M<V?G*)T>-W*L#&7ZC@
M\CFOF,%DF.X@H3Q?M5[C:Y7?>R>F^Y]+C,YP60UX83V7QI/F5MKVUVV/Z::*
M9;W"7=O'+$ZR1RJ'1E.0P(R"/;%?E+_P<@?\%`O%7P,UOP#\.?A[XNUWPMK<
MT4NNZS<:/?O:3^23Y5M$S1D-@LLS%<X^5#@\5\ODV4U<RQ<<)2=F[ZO9)*]V
M?2YQFM++\)+%U5=*VBW;;MH?J[17X2?\$-?B9\5OVV?VUUT;QM\7_BGJ7ACP
MSHT^NW6G_P#"4WR)J#))##'"Y60-LWS!R`1GR]IX)K]VZWS_`"5Y7B5A9S4I
M6N[+17VW,,BSE9GAWB80<8WLKO5VWV"BBBO#/:"BBFRLR1,RKO8`D+G&X^F:
M`'45^;?B;_@X]\*^$_CE/\/;[X3>-+/Q%9:W_8%W%<WUJBV]P)_(<$J6R`V>
M1UQ[YKVS_@M-^TI\5_V6?V-Y/$GPDL)9=9DU2*TU'4HK(7DFB6;1R,UR(V#+
M]]8TW,I5?,SC."/<?#N.A7HX>M%0=7X6VK/;6ZOW^?0\5<08*5"K7I2<U2^)
M).Z\K.W;_,^N**^"_P#@@C^UK\:OVL_@=XMU'XN+>:C:Z9J$$>@Z[<Z<EF^I
MJZR&>,;%1)%B98\,J_\`+0@DXP/M;XH_%'P_\%/A[J_BOQ5JMKHGA[0K=KJ^
MO;EML<$8[\<DDD`*`2Q(`!)`KDS#+:N$Q<L%)J4HNWNZIM]OO[;Z'7@,QI8O
M"QQD4XQDK^]HTEW_`*VU-ZBO@+X,?\%H_$?[<OQ9U/PK^SS\(9_$MMHB";4-
M?\4ZP-(L+6,DJC,D<<SY=@=JYWD*QV@!B/H?]E+X\?%WXD?$[QMX7^)WPOTS
MP2/"<=H]KK&FZT^H6&MF=6;$&^&,X0)\Q/(+`8YS6N+R7%X92==*+23:<H\R
M3LE[M[]5I:_78RPN<X7$M*@W)-M)J,N5M7;]ZUNCUO;H>[4445Y)Z@4444`%
M%!.T$D]*^:]&_P""K?PB\>?M<^&/@SX-UQ/&OB77VNOM-YI+K-INEK!;S3-O
MGSMD<^5M"Q;L;LL5Q@].'P=>NI.C!R44V[+9+5M]CGQ&+HT'%59*/,TE?JWI
M9=SZ4HHHKF.@****`"BBB@#S#]M3X/\`B#]H#]D[X@>"O"VKC0_$/B719[&Q
MO"[1JCLOW&9?F5'&48C)"N3@]#^+7_#5_@WX3>)?@QX7U#]F];/4O@AK>I:=
MXMAT.WMM4M/%5S'820R@SA6$L@8>:ZNS[%W'.`*_?2OP*_;/\<>+OV-OVT_$
M/A?P#XWT;PAHO@/QAJGB'P[:>)(D-Y875]I#37%Q'B)@]M)N,,&\L?,,8(&6
M-?H'!$_;>UPC5[)R6KCO%Q>L;]UNG;5JS5G\)QI'V/LL4G:[47HGLU):.W9Z
MIJ^B>CNOOG_@B)\*M5U"[^)GQKLM"TGX>_#CXP75O=^%_!>E7RW=K8)"'CDN
MCL^2.21L@HJJ00P*J%0#[\KP?_@F)\)=+^"W[!7POT?2;36+*&ZT2'5YX=5P
M+Q+B\'VJ82``!2))G&T`8``KWBOE<]Q7M\?5FMD[+TC[JOJVW9*[;;;/I\EP
M_L,#3@]VKOUEJ[:))7;LDDDCX>_X.'OB5_P@'_!,3Q19+.89_%>IZ?H\>.K_
M`+\7#K]#';O7XL_MQ_L7K^RM\/\`X'^(+9M0:V^*7@>VU^Y%VRDPWQ8M-&@`
M!"".2V(!R<NW/I^E?_!SSXWG\5:9\$_A3ITL;7_B?6YM1:(GE641VMN3[,US
M-_WP?2NC_P"#C']F"WC_`."=/@;5=/B61_A1J%I8B7RR66RFA%JPR.@,B6QY
M]*_1>$\=_9^'P5)NRKSFW]RC'\4C\_XJP7U^OC*J5W0A!+[W)_@V?4O_``2V
M_:<M?CK_`,$WOAYXUU6]CB?2=#^PZS<32#$4MB&@FED/;<(O-.>SBOQR^)'P
MXOO^"G4/[5/[3FLOJEMH'A".,>&XA(JAG$T20PN&!^6*S7+JN,O*I!Z@\9^S
M/_P4JO?@-_P35^+WP3MGU!=8\<:A`='FACS';V]PHCU%6?<""\44:*H!SYKG
MCO\`JC;_`+'*_LF_\&__`(T\%7%JMOKLO@:_UW7`1AC?RP&>16YY,85(LCJ(
M13>$_L+%U*RTE6JQC#RIW4I->6JB)8K^W,+3I/6-*DY3\YV<8K\'(^'_`/@U
MVNQ#^W5XOB/WIO!-QC\+VS-?JG_P43_X*>?#_P#X)Q>";.[\3_:M9\2:R&.D
M^'[%E%S>!3AI79OEBB!."[9)/"JQ!`_(+_@VM\3KH/\`P4FCM'?:=;\+ZC9H
M,_>93#/C\H2:X+_@O-XSU?Q=_P`%1OB/%JQF":+]BTZPB?.(K9;2)UVYZ*S2
M._'&9">]=>:Y!2S/B9TL0_<5-2:6[L[6^_<Y,LSVIEW#:J4%[[FXJ_2ZO?[M
MC]+/@K_P4"_;-_:]^#4GQ,^&_P`&OA;8>$9#,VG6>M:E=2:AK"Q$AC`0\2L-
MRL@9@@+*<9'-6?\`@G;_`,'`&@?M5?%JU^''Q%\,#X>>,]0N#9Z?*ERTMA>W
M(R/L[;P'@E+`A5;<&/RY#$`])^P+X<_:8\6?L3_"FT\/Z]\%_`7A./POIRZ=
M>)IU]KVJ3V_V9,22(TD$$<C9+,H+@,2,UD^"O^#=+X66_P`4+SQOXP\9>._%
M7BJ_U1M:FN+::#2;<7;3&9I$2%-R?O#D!9/EP,5\O7EDJ]O0Q<(PLVH>SYG)
M6;7O-OE?2^O?Y?345G#]A6PDY2NDY^TY5%W2^%)<RZ].WS]W_P""A?\`P5#^
M''_!.?PM:2^*9;K5_$VKQF33/#^GE3=W2`X,KECMBAW#&]NI!"AB"!\U_LC?
M\%;OVC/V_P"^U6]^%WP%\*0>&-,F,+ZKKOB&:*V5^"(O,6(>9)M()$:';D9Q
MD9_*G_@KW\6-5^,'_!2'XMWNJSRRG2-?N-#M$9B5@M[-C;QJH_A!$98@?Q.Q
M[FOZ#_\`@G%\)](^"O["?PIT+1($AM1X:LKV5E4`SW%Q"L\TK8ZEI)&.?>M\
MSR?`Y/E5&M4IJI6JVUDWRQTN[)-7M=+7U\C#+<WQF;9I5HTZCIT:71)7>ME=
MM/?5Z>GF?SQ_'74/$.J_\%2/$-QXLL].T_Q-+\1V.IVNGS--:V]Q_:`WI&[`
M%T!X#$`D#.!TK][?^"I7[?FL?\$Z/@CI?CBS\#V_C73;W4UTJ[5]6-BUD\D;
MO&^/)DWHWELIZ$$KUSQ^%?[77_*87QU_V52X_P#3G7ZV?\'+'_*-L?\`8U:?
M_P"@3U[W$-"EB<7EE&M%.,E9K5*S4>SOIZGB9!7JX?"9E5HRM*+NGH]4Y=U;
M\#OO^"1?_!4#4?\`@IAX=\<WU]X.L?"">$+FSMX8K;4&N_/$R2L228TQM\L8
MP.<^U?(/_!S9^U#X\TO0?#/PMFT2RT3P;K]T^J"^35%N+O6OLNT!7A4#R8E>
M56`8L790?EV$'6_X-2_^2=_&C_L(Z5_Z*NJ^:O\`@Y9^,/\`PG__``4&M_#D
M-SYMMX&\.VEB\8Z17$Y>Y<_4QRP@_P"[7#E>4X>EQ9/#T::Y*:YDM7;W5JM=
M^9];_D=F:9K7J\*PKUIOGJ.S>BO[ST>G9=+?F?1O_!O=X=^-'PQ_9?N=7\'_
M``[\%:UX9\<^(VFFUK5/$<EA>110[+=@(%MY/,2-EF9?G!)9AQUK[A\8?MT>
M+?$/QW\5_#SX5_!_7/'6H^"I8K76-<U'58-%T"TN)($F6)9V$LDKJLB;E2(L
MN>1C!KH_^":GPG/P0_8&^$GAMT\NXM/#5I<7*;-A6>=/M$H(]1)*PYYKPS]K
M'_@MO\,/V8_BP_PV\!^'K_XH_$>]U'[')I6@>7#;#4)'V>3+<8.Z<OM5@B.0
M<AB&!%?.8RI/-,TKRHX=5'=VUDE9.RE)\RV2[Q6OR/H<)".6991C6KNFK*^B
M;NU=QBK/J^TGI\SC/VX?^"H/[3'[`7A_3O$7C;X)_#ZZ\+:E=BS6_P!(\27%
MW';S%2RQ2%HD968*V&,>T[2,YP#]`_\`!,;_`(*5>'O^"E/PAU+7=,TFY\.Z
M]X=N4M-9TF6;SQ;LZEHY(Y0JAXW"OC(#`HP(Z$_$?_!=+Q;\?KW_`()]Z?>?
M%&'X7^&-)UWQ'9P'P]HHNKW4H9/+FF0/>.XB)01$,L<1!)X?`YH?\&J5M]N\
M+_':`NZ":31D+*<%<I?C(]Z]/%9-@Y\/3Q_)&-6$DKP;::YDM;MI[].RU/-P
MV<8N&?PP//*5.<;VFDFGRMZ62:VZ]]CVS]H3_@OOIEI^T]8?![X*^#H?B-XJ
MO]8CT(:G?:F+#2OM;2>44C8*S2HK8!DRJ\';N&"?HK5?B'^T[X!\)C6+[X??
M"GQK-!&9;G1O#_B.\L;TX!)6![FW,4K#IAC'N]17X=?M3_\`!&_]H3]D'XD7
MESIWA/Q%XJT?3;HW6F>)/#44EV2J/NCF98LS02+@$[@-K#AF`#5T'P6_X+T?
MM._LY7JZ;K'B"+Q=!:.HDL?%>G^;<*!P5,J^7/DCNS'GGUKUJ_"&%KT*<\F=
M.HDO>YG*\GZIZ>GNV[GE4>+<30KU(9PITVW[O*E:*]&M?76_8_<3XS?'GQNO
M[&#^//!/@9KGQ-J'A\:I_8NN7HT]]'+6IE=9\J2SQ'Y3&`-S#&Y1R/Y_O^".
M^N>-M)_X*+^!+[P#HVB^(O%:_P!H-;V&JWS6-I<*;&X$NZ958H1&7884Y8`8
MYK]I?V./^"CVF?\`!27]@[XA^)(M'?P]X@T#2[W3]9T[S?.BCE-F[I+$^`3&
MXS@,`058<X#'\A?^"`/_`"E8^&W_`%RU3_TVW51PU0GA,OS*C6I*,H)W3N_L
MR:3=]5V:M>^Y?$E>.*Q^75:51N,FK-67VHIM*VC[WO:VQ_0+^SWXB^(WB;PA
M=7'Q,\,^&_"NM+=LEO9Z+J\FJ0O;A$(D:1XHL.7+C:`0`H.><#O***_*JLU.
M3DHI7Z*]E][;_$_4*<7&*BVW;J[7_!)?@%%%%9EA1110`5^'7_!>;X<RVW_!
M2*R!B\Z3QQIMFME%J%E]MEO)/LUQ:>58ML98EWB)51_NW,PE.%RP_<6OSP_X
M*N?L(>*/VC?V\/V?O$'A_P`.:GJWAZ[ODTWQC=P7*I%:6=O*9E+EE)BS#->#
M</ODJHPVPGZO@[&PPV8.=1V3C)7?DK]?3]/,^8XNP<\3@%"FKM2B]/6W3U_4
M^_\`PCHO_"-^$]+TX2WLXL+2*V$EW-YUQ)L0+ND?^-SC);N<FH?'7CS2/AEX
M4O==U_4(-+TG3T#W%S,2$C!(`Z<DDD``<DD"M:BOE^9.5Y:]SZ5IJ-HZ'\^_
M[9W[66H?M5?\%9O"/Q.NO"7C27X8^"-<TJWL%?1+D2OIMK=+-+-Y>S=F1S-(
M%(W;653R,5^QW[2VE>'?V_OV$OB+H/A+48-?M_$FAW5K9/""I^V+'YL"E7`*
MD2B(X8`U[U17T>9<00Q"P_L*7LW024?>NM&GK[JUNM[GSV79#/#NO[:KSJLV
MY>[;=6TU>EGM8_G\_P""'G_!*WQ)^T9^T?IGCSQKX>OM-^'?@2\6\<:C;O"-
M9OHSNBMXU8#>B.%>0\KA0AY?C]6_^"PO[0&B?"C]AOXA^'YVN+[Q-XTT"ZTC
M2-*M+>2XN;M[A3"7"HIVH@9G+-@?)C.2`?JBBKS3B>IF&80QN(A[L+6BG;9W
MWL]WN[>6A.6<-T\!@)X.A/WIWO)J^ZMM=;+97\S^9[_@E9XCUS]D[]OGX=^.
M/$7AOQ39^'].O);;4K@:1<N+>"XMY;=I"%0L0GFAB`"<*<"OT:_X+%?\$JV_
MX*+V6F_&_P"!][INN^(S9"TU"P698DU^*(E4DBD<A5GC&8RKX#*JC(*8;]1Z
M*[\?QM6K8ZGF.'I\E2*Y=[IQNW9JR[]_Q.'`\&TJ."GE]>ISTY/FVLU*R5T[
MOMV/Q_\`^"8O_!2GQ]_P3^^&T'P=^._PD^*L-AH$CC1-4M-!GGFM8&;>8)$;
M;OC5F)1XV;`8+MP`:^T/A%_P4>\0?M3?'?P[X:^'OPD^(>G^#WG>;7O&'BK1
MI=,L;>W2)W$5LC<R2R.$0%BNT,3M;M]845Y&89QA,54GB/JRC.5[^\^6[^UR
MVWZ[VONF>I@<IQ6&IPH?6&X1M;W5S673FOMTVO;9GXG_`/!;[_@C3\1-7_:,
MUKXL_"WP]?\`C'1/&,@N]6TS38_-OM-O-H$CK"OS212%=^4#,'9P0!M)^@?^
M"6__``5!U/X5?LQ:-\/_`(S_``W^+>A:YX&M$TRQU"'P;J-Y%J=I&-L*,$B9
MXY40!"&&TA5.X$D#]+Z*ZZW%+Q6`A@,=24U"W+)/EDK:=FGIIM^.IS4N&EAL
M=/'8*HX.=^:+5XN^O=-:Z[_AH?S*_&;P3\0_BC^W=XA^*$/PH^)EIHNL^-9/
M$4<,GAN[,\=N]X9E5@(\;]G8'&:_5_\`X.&[R[^*O[`'AS1_"VB>(_$FI>*-
M?L]0L[?3=)N+B5;=()7:6150M&!YD8PX!RX&.#C]"Z*Z<9Q@Z^(PV(]BE[#9
M<SUVM?3I8Y\)PDJ&'Q-#VS?M]WRK3>]M?,_)_P#X-B?"NO?"BQ^+7A_Q3X:\
M3^&]1U233M0LQJFD7%I'=11B>.0H\B!25:1,KG.&SC`./SY^,=O=?\%`O^"O
MFMV6F[]0B\=?$`Z?;R1KO'V!+@0K+Q_"EM'O)_NJ37]!/[>'[0`_9G_90\9^
M*85GGUI+%K'0K2",RW%]J=Q^YM(8T&6=FF=/E4$X#''%?'7_``0V_P""/EY^
MR):GXK?$NV5?B1K-J8M-TQB'/AZVD`WF0_\`/U(/E;'W%)7.68#V\NXCIP>,
MSRK'EG42A"-[WDEK;R5HM_YV/%S#A^I-83):4N:%-N4Y6M9-Z7\W>27_``Y^
MA?C'1KR]\!:KIVC3)87\VGS6]C+C"VTIC*QM@=E;!X]*_F;^!.F?$K_@G/\`
MMW^&/$GBSX<^(K[7?!6L&XNM,N;20M?J59':*7:RL2KEDD7<-VUN:_I[HKY;
MA_B1Y9"M2E252-56:O9]5NK]&_\`,^FS[AY9C.E5C4<)4W=.UUT>VG9'Y`?\
M%==/^.G_``4K_92LO&ND?"SQ-X*\!>"+R*]MM`U6W,GB3Q#+,/*:[%K$&,4,
M"-@`_,PED;HHPO\`P;5^'O%7P9?XSZ#KWA/Q3X>UG6K&QU#23J>CW%M#=&W%
MRK*K2*JE@TT1VYR02>QQ^OU%;3XJ;RR>5JBE!NZLWIJGK>]]5JV^O16,8\,)
M9E#,W6;FE9W2UT:Z6MH]$NW5W/D;X'?\%9O"Z>`;&#XXZ1XB^"?CNU@1=4LO
M$6BW=K83R!1NFMKDQF)HF.2`SAAR"#C<?A__`(+5_M">"/\`@IE'X,\$_`7P
MEJOQ1\;6&IF:X\1Z1H<QCM[<1.IM!.R*75F=78G]VGE`[LDX_9AE#J58!@>H
M(R#200);1A(T6-1T50`!^5<V7YSA<'BEC:-%J:NTN?W4WY<MVO+F]6=./RC$
MXO#/!UJR<79-\GO.WGS63\^7T1\3_P#!*#_@F9K'[&/[#?B?PIXEN;5?''Q&
M2>XU5(W$L&F%[<PPV^]?O[`2S,,C<[!20`3^.7[+J_$/_@EE_P`%`/#/B+QA
M\/\`Q.+SP;?RPW]@EF^^\MY89()&@<C9)F.1F1@=K8'('-?TST5VY?QC6HSQ
M,L33515_B5^7HUH]=+.WW:G%C^$J56&'CAJCINA\+MS=4]5IK=7^_0^9?A=_
MP4OT_P"*'PI\7?$`_#?XC^&?!'ABVM3;7FOZ<EC=:]<SR>6L5K"7(9%8HIE9
MU7=(.P+#U?\`9C_:/TG]J3X:'Q+I%EJ.G11W3V<MO>HJRHZJC@_*2"K1R1N#
MP<.,@'(KM?$_AC3O&GAZ\TG6+&TU/3-1B:"ZM+J)98;B-A@JRMP0?0U3\`_#
MK0_A9X;CT?P[I5GH^FQR/*(+:,(I=V+.[=V9F))8Y))Y-?/5ZV$G"7LZ;C*^
MFMTE;K?=WU_R/H*-+%0G'VE12C;72S;OTMLK:?YFU1117GG<%%%%`!1110`4
M45\V?\%:(A<?L4:K"]A=:O%<>(?#L,NFV\PAEU.-];LE>V5RR`&524R64?-R
M0,FNG!T/;UX4+VYFE?M=V\OS1SXO$>PH3K6ORINW>ROY_DSZ3HKX,\&Q^,/V
M(-"^)?Q-T'X6:GX"\`VNDZ99Z=X!U3Q/'=OJFJ/J`CDOE,<MQ%9#RIDCVJY\
MPJ&91M!/LS?M#_&?6_'4W@;1?!/P_F\9Z!H\6N^(9[KQ!<QZ19K=3W"65G`Z
MVQFEG=+:1GD,:1IMXW[@!W5LIFFY4I*4>]XKHF[^\UI=+1M7:5[Z'%2S6+25
M6+4NUI/JTK:)ZV;U2=DWMJ?1M%?+'A#_`(*<Z;>:?;:UXD\/2>&_#M]X-U;Q
M##+)=B:==0T>ZDM]6TTX4(S1D(T3J?WJEB%&*XKXE?\`!5GQ!X`UAM$N/"_A
M33?%/AKP_I^K^)=)U/4[U9I+RZMOM7]F61@M)5:1(BH,LQ12[J`N`S`AD6-G
M)PC#5>:[V?7H]'V>X3SO!QBIN>C\GVNNG5:KNMC[<HKY+\6_M_>/=6N/&M]X
M)^'VBWF@>`O".F>-;^37M6FT^]N+:[LY;K[&D*PN$N52&3)=MBG:#U)7Z@\$
M>*X/'G@O1]<M5D2UUJRAOH5D&'5)8U=0??#"N3$X&M0BI55:_FGT3UMMHT]3
MJP^.HUY.--WMY-=6M+[ZJVAJ45\G^)?BOXY^'?\`P4"^)</A'X;ZQ\1X[GPE
MX;:=+77;+3H]-(FU;&5NI$#&3U3.-GS=J\F^$O[==]^SG\.?&MUK.B0Z9XO\
M>?&/7-.M]/UK4GDLM!\NUAGF-Q/;),62-$X6%6W,Z@%1N9>Z&25JD;TVF[1:
M5U?WE?57NK=VM3BGG5&$K5$TKR3=G;1VT=K._9/0_0FH9]2M[6[@MY;B&.>Z
M+"&-G"O-M&6V@\G`Y..@KY*T3_@I1J'B3X`W^OQV7@G2_$&E^)QX:>74M0OT
MTK5`8!.MS8*EHUW=%U8+Y"PAU99,MMC+'CM._:9U3]JCXN?L\^*--T73=/\`
M%>GZOXUT46EU-<)8/?6NGR1;][PK<)!(55OGA610V"F0<D<CQ*YG57*ES:Z;
MJ+DOOMOT'/.\/HJ;NWRZ:[.2B_NOMU/N>XOH;2:&.6:*.2Y<I$KN%:5@I;:H
M/4X!.!V!-2U^>W@SXS?&'XG_``:_9N\4ZSIWA3Q+XQU#X@7L.DLNH26\,R?V
M;K4+S79\@>6L2J3B)79U0#AFQ7M?@3]O776\3Z!I7B_POI>DG_A.[[X<>(+V
MRU!Y[6QU-;5+JPEA+1J6M[E'5#OVM'*Z+ALYI8C)*].ZBU)J][-=&UIU:T[;
MZ;A0SJC42<DXIVM=/JD]>B>O?;78^D=2\-Z?K.H6-W>65K=76F.TMI++$KO:
MNR[2Z$_=8J2,CG!(Z$U=KQKX8^+&_;G_`&4->N-3TXZ)H/CZ'5=-TLQ2N9[C
M2G>6WMKPY"E'FB`F4#.T2)R3S7Q7XJ^,OC;XU_!7X9W,%UJ$?BC]FWPH_C;Q
M;$MRP-[JVEZ@-.>UGV9SYT-CK#;3G.Y#C!HPN43K2<)2Y7%\KZVNG;KU:MY-
MH,5FT*,5.,>927,K=;-7Z=$[^:3['Z<T5\#^+?VX[+X=?'?QS\2K&:PU:/Q9
MKEC\-?",M_>RQZ1!;V%C)J-]?.T$<KE#-<R)A$+.T,8^499>V\$_MC6?[2+?
M#B;7?"4$VJZ9\3QX?CO+'4[V'31-_9%Y=QZA:EXX7N(S&#$T4R`*[/G=L5BZ
MF1XB$54:?+:]].UVK-K9Z/S3T%#.\/*3II^]>UM>]D[I=5JO*VI]A5%9ZA!J
M*R-;SQ3B*1HG,;APCJ<,IQT8'@CJ#7R-_P`/`/B7=_"GPU\4;;X<^&3\,_&>
MOZ;I6F>9K\JZU;6E[J$-G#?W$0@\K#^9N\E)"R[X\L?GV\E\`/VA_&OP#M_'
MNJ-X2T.[^&W_``NW5]"OKTZJZ:L9+_7#;+<PP"(QF**>XB5E:0.P$C#&%#"R
M3$<DF[73LE=:OJM]UIIU&\ZH<Z2O9J][/;H]MGKKTL?==%?/'[%_Q0^*_P`0
M_BE\6[3QTOA%]#\->*9M*LCIMW/)<6CBRL)E@4/!&'@VS.Y=FW^8[+C:%-7/
M@)<RR?MX?M!1-+*\<5IX8*(S,53-I=9P"<#..<=?PKEJ8"4'4C*2]R*EIK>[
MBK?^3?@=,,?&:@XQ?O2<==+64G?_`,E/>Z*^6_'O[<WCG2-!^(GCS0?`N@ZE
M\+?A9J-[I^K376M20:UJ2V#%=0N+6$0M$%A99`J22!I?);!0,N7Z5^WYK&J?
MM4W_`((DT#P]I>E03/%IMOJFI3V6M^)(19BXCO-/C>`6MS'([>4(EG\P;69@
MN"M6LHQ3BY)+1-O5:6M=/71JZT_X)#S;#)J+;U:2T>M[VMIMH]?^`?4-%?.W
M[#/[9NM?M47VM0:]IWA+0;[3K6WNI-%M=3NCK>BO(6WVM_9W-O"Z/'A1YR;H
MG;<%)VY/T37)BL+4P]1TJJLT=6&Q5/$4U5I.Z84445SFX4444`%%%%`!7*_&
M7X.:-\=O!::!KZW36$>HV.J`6\QB?SK.ZBNH?F';S84R.XR.]=515PJ2A)3@
M[-:HF<(SBX25T]SE_C-\(=(^._PXO_"NO"Z;2M2>!YOL\IBES#/'.F&'3YXU
MSZC(KD?C1^R'H7QB\>0^*H=>\9>#/%"Z=_9%QJGAC5387%]9;VD6";*LKJCL
M[(VT.A=]K#<<^K45K2Q56E;DDU:_XVO]]E]QE5PU*I?GC>]OPO;[KO[SQ;QG
M_P`$^_A;XY^%?@+P7=^'VB\/_#?4X-6T6"&=E998BQ997.6E28NQE#D^:6)8
MD\U;^+'[&>@?%'X@WOB>W\1^._!VKZS:16&L2>&-;?31K4,6[RA.%!^=`[JL
ML>R4*Q`?&,>O45HLPQ*:?.^O6^[N_O>OKKN9O`X=JW(NG3LK+[EIZ:'G-Y^R
MUX6O;GQ_*_\`:A;XE:);Z!K&Z\9R;:"">!-C-EE?9<29<DDG!/2HOA1\$M7^
M'?Q6UC4IO$%Q<^%(-!TKP]X<T59)/+TZ*U64S3R@G8\\KR(N\`$)"@]:]+HJ
M'BZKBXMW326OE;[M$EZ:%_5:2DI)6:=]/._ZMOUU.9T3X3:3X?\`BSX@\:6_
MVK^VO$UA8Z;>;I<P^5:-<-#M7'RMFZER>_R^E>?:_P#L(^"-<T;5((YO$6EZ
ME?\`BRX\:V^L6&HM!J6DZG/&(Y9+:4#Y$:/=&8V#(R.P8$'CV>BB&+K0?-&3
M3T_#1?AH.>%HS7+**:U_'5_CJ>)ZQ^PMH&M^&-`MKCQ=\1Y/$'AG5Y];L/$\
MFO--K,-Q/`UO,`\BM$L30N8_*6,1@8*JIYJQ\,_V%_!'PIUWPUJ>G2>(;B^\
M+:OJVN6DU]J;W,DUWJ<92[DF9OFD+Y9N3PS$U[)16CS#$N+@YNSO^-[_`"U>
MGF^YFL!AU)24%=6_"UOGHM?)=CQKX7_L.^%/A,=#CL-4\5W=AX7U^?Q%HEC>
MZB)K?2)IH;N&2&$;`WDE;R8[69B#M.>,5SW[37["=A\5OV>?B=X+\.BW@O/B
MMKT6N:E=ZE=28T^YS9QO<V^Q&*R1Q6BM&O`,@&6`8D?0U%..98E556YVY)I_
M<[_GKZDSR_#NDZ/*E%IK[U;\M/0SO"'A2P\">$]+T/2K=+33-&M(K&S@0`)#
M#$@1$`'0!5`_"N(^&/[*'@OX1^)_B-JVCZ?(ES\4]0.I:^LLF^.>4QE&"KCY
M5;<[$<Y:1SWKTBBN>.(J14DI/WM_/6^OSU.B5&FW%N*]W;RTMI\M#PSP]_P3
MP^'?@W]G?PI\-M#77M#TWP-?-JF@ZI8:@T.KZ9>.TI>X2X`^9F6>9&#JRLDA
M5E(KHM`_9,T+2M-\+17^M^,O$E[X3\0-XFM=0UK69+RZFO#;36WSD_*(A%.X
M$4:H@(!`SG/J-%;3S#$ROS3;NVWKU>_WW=S&.!P\;<L$K))>BV^ZRL?'?C/_
M`()F77B+0O#%KI%[<^&K+3?&-CXBE\.KXMO+WP_HL<&H)=RO8V[6Z;I9`CJL
M4FV&(SNRC*KGW&[_`&//!U]\/-7\,2+JITS6O%O_``FMP!=D2?VA_:*:CE6Q
MQ']HC7Y/[N1GO7J=%:ULUQ-1).3T=UZ][[_UW,Z668:FVU%:JS].UMOZ['G_
M`(%_9STKX<?&7Q5XSTO5_$D3^,I1=:CH[WH?26NO*@A-TD)7<LQCMXU)#[3@
MG;DYKE?B+^P_I'COXM:WXTLO&WQ+\'ZQXBAM8=27P[K@LK>[%LC)"S(8V^95
M9AG/.:]JHK"..KQESJ6MDODK67X+[C:>#HRCR..E[_-WN_Q?WG@GBG_@G5X(
M\7:QJS7&L>.(M"\2W27WB#PY;ZV\>C^(;@!`\MS"%R3-L7S0C(LN#O5LMG5\
M1?L/>&?%_P`4K?Q+J^O^/-3M;#4SK5CH%QKTK:1IU[Y+0K/!%]^(HKL419`B
M,Q95!YKV:BM/[2Q7\[VM_7R25][*Q']GX;^1;W^[_@MNVUSR?X&?L?:%\#?'
M=YXH77_&OBWQ#<Z7'HD6H>)=7;4)[*PCD,HMXV*K\I<[F9]TC%1ECBO6***Y
MJU>I5ESU'=F]&C"E'DIJR"BBBLC4****`"BBB@`HHHH`****`"BBB@`HHHH`
J****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
